204 related articles for article (PubMed ID: 16264828)
1. Technology insight: Identification of biomarkers with tissue microarray technology.
Giltnane JM; Rimm DL
Nat Clin Pract Oncol; 2004 Dec; 1(2):104-11. PubMed ID: 16264828
[TBL] [Abstract][Full Text] [Related]
2. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Camp RL; Neumeister V; Rimm DL
J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarrays: applications in genomic research.
Watanabe A; Cornelison R; Hostetter G
Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.
Tzankov A; Went P; Zimpfer A; Dirnhofer S
Exp Gerontol; 2005; 40(8-9):737-44. PubMed ID: 16125349
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
[TBL] [Abstract][Full Text] [Related]
6. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.
Brennan DJ; Kelly C; Rexhepaj E; Dervan PA; Duffy MJ; Gallagher WM
Cancer Genomics Proteomics; 2007; 4(3):121-34. PubMed ID: 17878516
[TBL] [Abstract][Full Text] [Related]
7. Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice.
Abdullah-Sayani A; Bueno-de-Mesquita JM; van de Vijver MJ
Nat Clin Pract Oncol; 2006 Sep; 3(9):501-16. PubMed ID: 16955089
[TBL] [Abstract][Full Text] [Related]
8. Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques.
Sullivan CA; Chung GG
Clin Colorectal Cancer; 2008 May; 7(3):172-7. PubMed ID: 18621634
[TBL] [Abstract][Full Text] [Related]
9. Array of hope: expression profiling identifies disease biomarkers and mechanism.
Bhattacharya S; Mariani TJ
Biochem Soc Trans; 2009 Aug; 37(Pt 4):855-62. PubMed ID: 19614607
[TBL] [Abstract][Full Text] [Related]
10. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
11. Strategies for plasma proteomic profiling of cancers.
Omenn GS
Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
[TBL] [Abstract][Full Text] [Related]
12. DualChip microarray as a new tool in cancer research.
Gillet JP; de Longueville F; Remacle J
Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
[TBL] [Abstract][Full Text] [Related]
13. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
[TBL] [Abstract][Full Text] [Related]
14. Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor.
Wirth GJ; Schandelmaier K; Smith V; Burger AM; Fiebig HH
Oncology; 2006; 71(1-2):86-94. PubMed ID: 17347587
[TBL] [Abstract][Full Text] [Related]
15. Classification of breast cancer using genetic algorithms and tissue microarrays.
Dolled-Filhart M; Rydén L; Cregger M; Jirström K; Harigopal M; Camp RL; Rimm DL
Clin Cancer Res; 2006 Nov; 12(21):6459-68. PubMed ID: 17085660
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue microarray in the era of target-based agents.
Franco R; Caraglia M; Facchini G; Abbruzzese A; Botti G
Expert Rev Anticancer Ther; 2011 Jun; 11(6):859-69. PubMed ID: 21707283
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
[TBL] [Abstract][Full Text] [Related]
19. Microarray technology in biomedical research.
Shomaker TS; Ward K
Hawaii Med J; 2006 Sep; 65(9):253-6. PubMed ID: 17153668
[TBL] [Abstract][Full Text] [Related]
20. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Lancashire LJ; Rees RC; Ball GR
Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]